Unravelling the utility of modern sulfonylureas from cardiovascular outcome trials and landmark trials: expert opinion from an international panel

AIM: The primary objective of this review is to develop practice-based expert group opinions on the cardiovascular (CV) safety and utility of modern sulfonylureas (SUs) in cardiovascular outcome trials (CVOTs). BACKGROUND: The United States Food and Drug Administration issued new guidance to the pha...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalra, S., Ghosh, S., Das, A.K., Nair, T., Bajaj, S., Priya, G., Mehrotra, R.N., Das, S., Shah, P., Deshmukh, V., Chawla, M., Sanyal, D., Chandrasekaran, S., Khandelwal, D., Joshi, A., Eliana, F., Permana, H., Fariduddin, M.D., Shrestha, P.K., Shrestha, D., Kahandawa, S., Sumanathilaka, M., Shaheed, A., Rahim, A.A., Orabi, A., Al-ani, A., Hussein, W., Kumar, D., Shaikh, K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231843/
https://www.ncbi.nlm.nih.gov/pubmed/32423565
http://dx.doi.org/10.1016/j.ihj.2020.01.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231843/
https://www.ncbi.nlm.nih.gov/pubmed/32423565
http://dx.doi.org/10.1016/j.ihj.2020.01.001

Ejemplares similares